 Q BioMed Inc has given itself a big shot in the arm, adding a multi-million dollar asset in the form of an equity stake in long term partner Mannin Research, which has a drug development pipeline poised to be a multi-billion dollar blockbuster franchise for years to come. The company has converted its long-term royalty agreement into a 15 equity stake in private Mannin - a holding, which has a current valuation of C30 million. 